Bone Health History in Breast Cancer Patients on Aromatase Inhibitors

A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis, which may impact fracture risk after AI therapy and choice of initial hormonal therapy. A total of 2,157 invasive BC patients initially treated with an AI wer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kwan, Marilyn L., Lo, Joan C., Tang, Li, Laurent, Cecile A., Roh, Janise M., Chandra, Malini, Hahn, Theresa E., Hong, Chi-Chen, Sucheston-Campbell, Lara, Hershman, Dawn L., Quesenberry, Charles P., Ambrosone, Christine B., Kushi, Lawrence H., Yao, Song
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213031/
https://ncbi.nlm.nih.gov/pubmed/25354083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0111477
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller